680
M. Kordian et al. · Anellation and Ring Transformations of Push-pull-functionalized Deoxypyranosiduloses
Ethyl (2R,4aR,6S,12bS)-4a,12b-dihydro-6-methoxy -9-meth- Ethyl 6-(2,4-di-O-benzylidene-D-erythronoyl)-2-methyl-
ylsulfanyl-2-phenyl-4H,6H-[1,3]-dioxino[4ꢀ,5ꢀ:5,6]pyrano-
[3,4-d]pyrazolo[1,5-a]pyrimidine-8-carboxylate (8a)
sulfanyl-pyrazolo[1,5-a]pyrimidine-3-carboxylate (10a)
A solution of◦6 (319 mg, 1.0 mmol) in DMF (5 mL) was
cooled to −15 C. While stirring under argon atmosphere
potassium carbonate (830 mg, 6 mmol), 18-crown-6 (1.32 g,
5 mmol) and 7a (402 mg,◦2.0 mmol) were added. The suspen-
sion was stirred at −15 C until complete conversion (TLC
control). Then the reaction mixture was added to an ice/water
mixture and the product precipitated from the solution. The
solid was filtered and the aqueous phase extracted several
times with dichloromethane. The organic phases were com-
bined and dried with Na2SO4. After removal of the solvent
the combined solids were purified by column chromatogra-
phy (toluene/ethyl acetate = 1 : 1). For further purification
the product was recrystallized from ethyl acetate. – Yield
A solution of compound 5 (319 mg, 1.0 mmol) in
abs. THF (30 mL) was cooled to 0 ◦C. At this temper-
ature ethyl 5(3)-amino-3(5)-methylsulfanyl-1H-pyrazole-4-
carboxylate (7a, 402 mg, 2.0 mmol) and NaH (60 %; 150 mg,
3.75 mmol) were added. The solution was allowed to warm
◦
to 22 C and stirred until completion of the reaction (TLC-
control). Then ice water (100 mL) was added, the aque-
ous phase was extracted with dichloromethane (3 × 40 mL)
and dried with Na2SO4. Removal of the solvent under re-
duced pressure and purification of the residue by column
chromatography (toluene/ethyl acetate = 3 : 1) gave the pure
compound 8a. – Yield 180 mg (40 %, amorphous powder). –
[α]2D1 = +42.6 (c = 1.0, CHCl3). – Rf = 0.7 (toluene/ethyl ac-
etate = 1 : 1). – 1H NMR (250 MHz, CDCl3): δ = 8.74 (s,
1 H, 12-H), 7.49 – 7.33 (5 H, Ph), 5.81 (s, 1 H, 2-H), 5.73 (s,
112 mg (22 %, solid). – M. p. 211 – 213.5 ◦C. – [α]D22
=
−12.4◦ (c = 1.8, DMSO). – Rf = 0.3 (toluene/ethyl acetate =
1 : 1). – 1H NMR (250 MHz, [D6]DMSO): δ = 9.97 (d,
3
4
4
1 H, 6-H), 4.78 (d, 1 H, J12b−4a = 9.2 Hz, 12b-H), 4.44 –
1 H, J7−5 = 2.1 Hz, 7-H), 9.20 (d, 1 H, J5−7 = 2.1 Hz,
4.23 (m, 4 H, 4a-H, 6-H, CH2CH3), 3.93 (t, 1 H, 2J4ax−4eq
=
5-H), 7.49 – 7.37 (5 H, Ph), 5.87 (s, 1 H, 2ꢀ-H), 5.58 (d, 1 H,
3J4ax−4a = 10.1 Hz, 4ax-H), 3.69 (s, 3 H, OMe), 2.57 (s,
3 H, SMe), 1.36 (t, 3 H, 3J = 7.0 Hz, CH2CH3). – 13C NMR
(125.7 MHz, CDCl3): δ = 162.7 (C=O), 160.4 (C-9), 149.0
(C-7a), 148.7 (C-12), 138.2 (C-6a), 136.7, 129.4, 128.4,
126.2 (Ph), 115.9 (C-12a), 102.3 (C-2), 100.4 (C-6), 94.3
(C-8), 73.4 (C-12b), 68.9 (C-4), 64.4 (C-4a), 60.5 (CH2
CH3), 57.9 (OCH3), 14.5 (SMe), 13.4 (CH2CH3). – MS
(EI, 70 eV): m/z (%) = 457 (100) [M]+. – C22H23N3O6S
(457.50): calcd. C 57.76, H 5.07, N 9.18, S 7.01; found
C 57.66, H 5.01, N 9.07, S 6.74.
JOH−5 = 5.8 Hz, OH), 5.28 (d, 1 H, 3J4 −5 = 9.1 Hz, 4ꢀ-H),
3
ꢀ
ꢀ
ꢀ
3
4.31 (q, 2 H, JCH CH = 7.0 Hz, CH2CH3), 4.25 (dd, 1 H,
2
2
33
J6 ax−6 eq = 10.7 Hz, J5−6 eq = 5.2 Hz, 6ꢀeq-H), 3.94 (m,
ꢀ
ꢀ
ꢀ
1 H, 5ꢀ-H), 3.73 (t, 1 H, J6 ax−6 eq
= J5 −6 ax = 10.7 Hz,
2
3
ꢀ
ꢀ
ꢀ
ꢀ
6ꢀax-H), 2.60 (s, 3 H, SMe), 1.32 (t, 3 H, 3JCH CH = 7.0 Hz,
CH2CH3). – 13C NMR (75.5 MHz, [D6]DMSO):3δ = 191.9
(C=O), 162.4 (COOEt), 161.9 (C-2), 149.2 (C-5), 137.8
(C-7), 129.3, 128.5, 126.6 (Ph), 118.5 (C-3a), 100.4 (C-2ꢀ),
80.7 (C-4ꢀ), 71.1 (C-6ꢀ), 62.1 (C-5ꢀ), 60.3 (CH2CH3), 14.8
(SMe), 13.4 (CH2CH3). – MS (EI, 70 eV): m/z (%) = 443
(1) [M]+. – C21H21N3O6S (443.47): calcd. C 56.87, H 4.77,
N 9.48, S 7.23; found C 56.56, H 4.80, N 9.38, S 7.68.
2
(2R,4aR,6S,12bS)-9-Amino-4a,12b-dihydro-6-methoxy-2-
phenyl-4H,6H-[1,3]dioxino[4ꢀ,5ꢀ:5,6]pyrano[3,4-d]pyr-
azolo[1,5-a]pyrimidine-8-carbonitrile (8b)
2-(p-Anisidino)-6-(2,4-di-O-benzylidene-D-erythronoyl)
pyrazolo[1,5-a]pyrimidine-3-carbonitrile (10b)
Compound 5 (319 mg, 1.0 mmol) was reacted with 3,5-
diamino-1H-pyrazole-4-carbonitrile (7b, 181 mg, 2.0 mmol)
as described for the preparation of 8a. After removal of the
solvent the residue was purified by column chromatography
(toluene/ethyl acetate = 1 : 1). – Yield 265 mg (70 %, col-
Compound 6 (319 mg, 1.0 mmol) was reacted with
5(3)-amino-3(5)-(p-anisidino)-1H-pyrazol-4-carbonitrile
(7c, 458 mg, 2.0 mmol) as described for the preparation of
10a. After removal of the solvent the residue was purified
by column chromatography (ethyl acetate/chloroform =
5 : 1). – Yield 87 mg (18 %, solid). – M. p. > 360 ◦C. –
[α]2D4 = −24.5◦ (c = 0.8, DMSO). – Rf = 0.5 (ethyl acetate/
chloroform = 5 : 1). – 1H NMR (250 MHz, [D6]DMSO): δ =
◦
orless needles). – M. p. 303 C. – [α]2D1 = +52.3 (c = 1.0,
DMSO). – Rf = 0.4 (toluene/ethyl acetate = 1 : 1). – 1H NMR
(250 MHz, [D6]DMSO): δ = 8.53 (s, 1 H, 12-H), 7.55 – 7.38
(5 H, Ph), 6.90 (s, 2 H, NH2), 5.95 (s, 1 H, 2-H), 5.84 (s,
1 H, 6-H), 4.98 (d, 1 H, 3J12b−4a = 8.9 Hz, 12b-H), 4.39 (dd,
2
3
4
1 H, J4eq−4ax = 8.9 Hz, J4eq−4a = 3.4 Hz, 4eq-H), 4.12 –
9.76 (d, 1 H, J7−5 = 2.1 Hz, 7-H), 9.61 (s, 1 H, NH), 9.41
3.98 (m, 2 H, 4a-H, 4ax-H), 3.58 (s, 3 H, OMe). – 13C NMR (d, 1 H, 4J5−7 = 2.1 Hz, 5-H), 7.62 (d, 2 H, Ar), 7.43 – 7.34
(62.9 MHz, [D6]DMSO): δ = 161.8 (C-9), 150.9 (C-7a), (5 H, Ph), 6.91 (d, 2 H, Ar), 5.81 (s, 1 H, 2ꢀ-H), 5.55 (d, 1 H,
3
ꢀ
ꢀ
ꢀ
147.1 (C-12), 138.4 (C-6a), 137.4, 129.3, 128.4, 126.5 (Ph),
JOH−5 = 5.8 Hz, OH), 5.22 (d, 1 H, 3J4 −5 = 9.2 Hz, 4ꢀ-H),
2 3
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ
116.1 (C-12a), 113.9 (CN), 101.3 (C-2), 93.3 (C-6), 72.5 4.22 (dd, 1 H, J6 ax−6 eq = 10.7 Hz, J5 −6 eq = 5.2 Hz,
(C-12b), 67.9 (C-4), 66.8 (C-8), 64.1 (C-4a), 56.8 (OCH3). – 6ꢀeq-H), 3.93 (m, 1 H, 5ꢀ-H), 3.73 (s, 4 H, OMe, 6ꢀax-H). –
MS (EI 70 eV): m/z (%) = 379 (36) [M]+. – C19H17N5O4 13C NMR (75.5 MHz, [D6]DMSO): δ = 191.6 (C=O),
(379.37): calcd. C 60.15, H 4.52, N 18.46; found C 60.59, 158.9 (C-2), 155.3 (C-6), 152.1 (C-5), 139.8 (C-7), 137.9,
H 5.02, N 17.89.
133.4, 129.6, 128.5, 126.6, 121.3, 114.4 (Ar, Ph), 118.8
Unauthenticated
Download Date | 3/28/19 6:47 AM